• Liver sEH–Nrf2 Control of Osteoclastogenesis

  2026-08-22

  A 2025 study identifies a liver–bone axis in which hepatic soluble epoxide hydrolase alters circulating epoxide metabolites and inflammatory signals, thereby suppressing Nrf2-ARE activity in bone and promoting osteoclast differentiation. Its integrated clinical, animal, cellular, and transcriptomic design provides a mechanistic framework for studying redox imbalance in osteoporosis and related enzyme inhibition studies.

• Dual-Action p38α Inhibitors and Dephosphorylation

  2026-08-22

  A 2024 bioRxiv preprint shows that selected kinase inhibitors can do more than occupy the p38α catalytic site: they can also accelerate activation-loop dephosphorylation by WIP1. Structural and biochemical evidence supports a mechanism in which inhibitor-stabilized loop conformations expose phospho-threonine, suggesting a route to more durable and target-selective kinase inhibition.

• Gemcitabine Workflows for DNA Damage Research

  2026-08-21

  Gemcitabine provides a practical benchmark for connecting replication stress with checkpoint activation, cell-cycle arrest, and apoptosis. This workflow combines dose-ranging, orthogonal phenotyping, and transcriptomics-informed assay design for cancer research, including osteosarcoma models.

• Linoleic Acid–PPARα–TF Signaling in pLELC

  2026-08-20

  This reference study integrates serum proteomics, untargeted metabolomics, functional testing, and a patient-derived xenograft model to investigate primary pulmonary lymphoepithelioma-like carcinoma. It proposes a linoleic acid–PPARα–tissue factor axis that reshapes immune-cell infiltration and promotes tumor progression, positioning tissue factor as a candidate therapeutic target while highlighting the context dependence of PPARα signaling.

• Aprotinin Workflows for Protease-Controlled Assays

  2026-08-20

  Aprotinin enables reversible control of trypsin, plasmin, and kallikrein in blood, cell, and inflammation research workflows. This guide connects fibrinolysis inhibition and cardiovascular surgery blood management models with membrane-biophysics assay design, while emphasizing formulation controls and troubleshooting.

• Pyridostatin TFA in G-Quadruplex Research

  2026-08-19

  Pyridostatin TFA provides a practical way to stabilize G-quadruplexes while connecting telomere biology research with emerging studies of nucleic-acid-regulated protein condensation. This workflow-focused guide covers dose design, assay controls, comparative applications, and troubleshooting for cancer and neurodegeneration-oriented experiments.

• Streptozotocin: Designing Causal Diabetes Models

  2026-08-19

  Streptozotocin enables controlled experimental diabetes mellitus induction through selective pancreatic β-cell cytotoxicity. This guide moves beyond model generation to show how STZ can support rigorous causal studies of diabetic neuropathy, inflammation, and therapeutic response.

• Methicillin Sodium Salt for MSSA Research

  2026-08-18

  Build reproducible MSSA susceptibility, cell-wall stress, and infection-model workflows with Methicillin sodium salt. This guide distinguishes actionable MSSA benchmarking from MRSA resistance analysis and provides practical setup, optimization, and troubleshooting strategies.

• Ribonuclease R (RNase R) (20 U/μL) Guide

  2026-08-18

  Learn how Ribonuclease R (RNase R) (20 U/μL), SKU K3061, can strengthen circular RNA validation before interpreting cell proliferation, viability, or cytotoxicity phenotypes. This scenario-driven guide covers experimental controls, protocol calculations, data interpretation, and practical product-selection criteria.

• TRIM21, ERK1/2, and Drug Resistance in Pituitary Adenomas

  2026-08-17

  The reference study identifies TRIM21 as a regulator of pituitary adenoma proliferation and dopamine-agonist resistance through K27-linked ubiquitination and phosphorylation of ERK1/2. Its combination of CRISPR screening, proteomics, interaction assays, animal studies, and NanoBiT drug screening positions TRIM21 as a mechanistically testable therapeutic target and highlights Quisinostat as a candidate for reducing resistance-associated signaling.

• Neurotensin Workflows for GPCR Trafficking

  2026-08-17

  Turn Neurotensin receptor 1 activation into a structured workflow for receptor recycling, miR-133α modulation, and gastrointestinal cell studies. This guide combines peptide-handling discipline with interference-aware fluorescence analysis and practical troubleshooting.

• SM-164: Bivalent Smac Mimetic Assay Guide

  2026-08-16

  SM-164 provides a practical way to connect rapid IAP degradation with TNFα-dependent apoptosis, caspase activation, and tumor-cell killing. This workflow guide shows how to use it as a mechanistic apoptosis probe, an orthogonal comparator for transcriptional inhibitors, and a reproducible tool for cancer research.

• Protease and Phosphatase Inhibitor Cocktail Workflow

  2026-08-15

  Protect phosphorylation-dependent signaling data and protein integrity across cell, organoid, tissue, plant, yeast, and bacterial lysates. This EDTA-free 100X format is especially useful when metal chelation could interfere with downstream assays or when rapid, standardized sample stabilization is essential.

• Biotin (Vitamin B7) for Motor Protein Assays

  2026-08-14

  Biotin (Vitamin B7) enables controlled avidin–streptavidin capture, blocking, and detection workflows for reconstituted motor-protein experiments. This guide connects A8010’s practical solution chemistry with the BicD–MAP7–kinesin findings, while clarifying when free biotin is appropriate and when an activated biotinylation reagent is required.

• DAPI Nuclear Stain Solution Protocol

  2026-08-14

  DAPI (4',6-Diamidino-2-Phenylindole) Nuclear Stain Solution provides a pre-diluted fluorescent DNA binding dye for nuclear visualization and endpoint cell viability assessment. It is best suited to fixed or membrane-compromised samples analyzed by fluorescence microscopy or flow cytometry, not primary live-cell imaging.

3689 records 10/246 page Previous Next First page 上5页 678910 下5页 Last page